These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6631676)

  • 21. [The search for new antiallergy compounds among a number of coumarin derivatives and the study of their mechanisms of action].
    Saraf AS; Simonian AV; Oganesian ET
    Eksp Klin Farmakol; 1993; 56(2):47-50. PubMed ID: 7688624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of rotenone.
    Santi R; Ferrari M; Tóth E
    Farmaco Sci; 1966 Oct; 21(10):689-703. PubMed ID: 6008413
    [No Abstract]   [Full Text] [Related]  

  • 23. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
    Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
    Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological study of 2-(2,4-dimethoxyphenyl)-3-methyl-2-butanol].
    Cahen R; Boucherle A; Pessonier J; Pessonier A; Rambert F
    Therapie; 1966; 21(4):971-87. PubMed ID: 5925092
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacological properties of N,N-bis-aminoacyl(phenylenediamines)].
    Kostowski W; Radecki K; Kwapiszewski W; Grabowska B; Strzałkowska M; Witanowska A
    Acta Pol Pharm; 1978; 35(3):379-83. PubMed ID: 211800
    [No Abstract]   [Full Text] [Related]  

  • 26. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
    Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the antifungal effect of an ointment containing diethanolamine compared with Mycodermine ointment].
    Baran E; Witek R; Kubis A; Nespiak A
    Przegl Dermatol; 1980; 67(3):293-300. PubMed ID: 7433698
    [No Abstract]   [Full Text] [Related]  

  • 28. General pharmacology of pidotimod and testing for drug interactions.
    Manzardo S; Falcone A; Pinzetta A; Ieva G; Coppi G
    Arzneimittelforschung; 1994 Dec; 44(12A):1441-7. PubMed ID: 7857339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil.
    Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N
    Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [EXPERIMENTAL SURFACE DERMATOMYCOSIS IN GUINEA PIGS AND RABBITS].
    DOBROMYSLOV VV; DROZDOV AI; KONEV IuE
    Vestn Dermatol Venerol; 1964 Aug; 38():21-5. PubMed ID: 14240335
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methyl-1-naphthyldithiocarbaminic acid-2-benzoxazolyl ester (K-F 224), a new local antimycotic agent].
    Wildfeuer A
    Mykosen; 1971 Feb; 14(2):67-82. PubMed ID: 5548032
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemical, pharmacological and oncostatic properties of 5-(4'-hydroxybenzylidenoimino)-4, 6-diketo-4, 5, 6, 7-tetrahydropyrimidine-[4, 5-d]-3-methyl-isothiazole (compound IP-10).
    Machoń Z; Giełdanowski J; Wieczorek Z; Raberger G; Kowalczyk-Bronisz SH; Błaszczyk B; Zimecki M; Mordarski M; Fiszer-Maliszewska L; Wieczorek J
    Arch Immunol Ther Exp (Warsz); 1983; 31(5):769-94. PubMed ID: 6675577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding sites for 2-haloalkylamines.
    Mottram DR; Graham JD
    Br J Pharmacol; 1970 Sep; 40(1):157P-158P. PubMed ID: 5487012
    [No Abstract]   [Full Text] [Related]  

  • 34. General pharmacology of ceftizoxime sodium.
    Honda F; Ono T; Itoh N; Mori J; Ohtsuka M; Kamitani T
    Arzneimittelforschung; 1980; 30(10):1680-7. PubMed ID: 6933995
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
    Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
    Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenergic activity of methyl-alpha-(p-nitrophenyl)-beta-(1-pyrrolidinyl) propionate.
    Riera de Narvaez AJ; Vicuña Fernández N
    J Pharm Belg; 1993; 48(5):357-64. PubMed ID: 8120788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
    Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
    Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
    Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
    Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552).
    Kazda S; Garthoff B; Meyer H; Schlossmann K; Stoepel K; Towart R; Vater W; Wehinger E
    Arzneimittelforschung; 1980; 30(12):2144-62. PubMed ID: 7194077
    [No Abstract]   [Full Text] [Related]  

  • 40. [The topical treatment of tinea with tolnaftate].
    Magaña M
    Medicina (Mex); 1965 Sep; 45(971):435-9. PubMed ID: 5847820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.